Do younger men have better biochemical outcomes after radical prostatectomy?

Stephen J. Freedland, Joseph C. Presti, Christopher J. Kane, William J. Aronson, Martha Kennedy Terris, Frederick Dorey, Christopher L. Amling

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

OBJECTIVES: To examine the relationship between age and biochemical failure after radical prostatectomy (RP), controlling for the year of surgery. Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery. METHODS: We examined the data from 1753 men treated with RP between 1988 and 2002 at five equal access medical centers. We compared age, as a categorical variable according to decade of life (50 years old or younger, 51 to 60, 61 to 70, and older than 70 years), with the clinical and pathologic variables at RP, as well as the time to biochemical recurrence, using a multivariate Cox proportional hazards model. RESULTS: Age was significantly related to the year of surgery, with the more recently treated patients being younger than less recently treated patients (P <0.001). After controlling for the year of surgery, the younger men had smaller prostates, fewer high-grade tumors on biopsy, and less lymph node metastasis, but a greater percentage of cores with cancer. On multivariate analysis, men 50 years old or younger had significantly lower recurrence rates than did the older men. Moreover, men older than 70 years had significantly greater prostate-specific antigen failure rates than men aged 51 to 70 years or men aged 50 years or younger. CONCLUSIONS: The average age of men undergoing RP has decreased with time. Independent of this, young men have more favorable outcomes after RP than older men. Continued screening to detect prostate cancer among younger men when it is most curable appears warranted.

Original languageEnglish (US)
Pages (from-to)518-522
Number of pages5
JournalUrology
Volume63
Issue number3
StatePublished - Jan 1 2004
Externally publishedYes

Fingerprint

Prostatectomy
Prostate-Specific Antigen
Recurrence
Proportional Hazards Models
Prostate
Neoplasms
Prostatic Neoplasms
Multivariate Analysis
Lymph Nodes
Neoplasm Metastasis
Biopsy

ASJC Scopus subject areas

  • Urology

Cite this

Freedland, S. J., Presti, J. C., Kane, C. J., Aronson, W. J., Terris, M. K., Dorey, F., & Amling, C. L. (2004). Do younger men have better biochemical outcomes after radical prostatectomy? Urology, 63(3), 518-522.

Do younger men have better biochemical outcomes after radical prostatectomy? / Freedland, Stephen J.; Presti, Joseph C.; Kane, Christopher J.; Aronson, William J.; Terris, Martha Kennedy; Dorey, Frederick; Amling, Christopher L.

In: Urology, Vol. 63, No. 3, 01.01.2004, p. 518-522.

Research output: Contribution to journalArticle

Freedland, SJ, Presti, JC, Kane, CJ, Aronson, WJ, Terris, MK, Dorey, F & Amling, CL 2004, 'Do younger men have better biochemical outcomes after radical prostatectomy?', Urology, vol. 63, no. 3, pp. 518-522.
Freedland SJ, Presti JC, Kane CJ, Aronson WJ, Terris MK, Dorey F et al. Do younger men have better biochemical outcomes after radical prostatectomy? Urology. 2004 Jan 1;63(3):518-522.
Freedland, Stephen J. ; Presti, Joseph C. ; Kane, Christopher J. ; Aronson, William J. ; Terris, Martha Kennedy ; Dorey, Frederick ; Amling, Christopher L. / Do younger men have better biochemical outcomes after radical prostatectomy?. In: Urology. 2004 ; Vol. 63, No. 3. pp. 518-522.
@article{6b4d3889994b442ab74d941c93501bc7,
title = "Do younger men have better biochemical outcomes after radical prostatectomy?",
abstract = "OBJECTIVES: To examine the relationship between age and biochemical failure after radical prostatectomy (RP), controlling for the year of surgery. Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery. METHODS: We examined the data from 1753 men treated with RP between 1988 and 2002 at five equal access medical centers. We compared age, as a categorical variable according to decade of life (50 years old or younger, 51 to 60, 61 to 70, and older than 70 years), with the clinical and pathologic variables at RP, as well as the time to biochemical recurrence, using a multivariate Cox proportional hazards model. RESULTS: Age was significantly related to the year of surgery, with the more recently treated patients being younger than less recently treated patients (P <0.001). After controlling for the year of surgery, the younger men had smaller prostates, fewer high-grade tumors on biopsy, and less lymph node metastasis, but a greater percentage of cores with cancer. On multivariate analysis, men 50 years old or younger had significantly lower recurrence rates than did the older men. Moreover, men older than 70 years had significantly greater prostate-specific antigen failure rates than men aged 51 to 70 years or men aged 50 years or younger. CONCLUSIONS: The average age of men undergoing RP has decreased with time. Independent of this, young men have more favorable outcomes after RP than older men. Continued screening to detect prostate cancer among younger men when it is most curable appears warranted.",
author = "Freedland, {Stephen J.} and Presti, {Joseph C.} and Kane, {Christopher J.} and Aronson, {William J.} and Terris, {Martha Kennedy} and Frederick Dorey and Amling, {Christopher L.}",
year = "2004",
month = "1",
day = "1",
language = "English (US)",
volume = "63",
pages = "518--522",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Do younger men have better biochemical outcomes after radical prostatectomy?

AU - Freedland, Stephen J.

AU - Presti, Joseph C.

AU - Kane, Christopher J.

AU - Aronson, William J.

AU - Terris, Martha Kennedy

AU - Dorey, Frederick

AU - Amling, Christopher L.

PY - 2004/1/1

Y1 - 2004/1/1

N2 - OBJECTIVES: To examine the relationship between age and biochemical failure after radical prostatectomy (RP), controlling for the year of surgery. Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery. METHODS: We examined the data from 1753 men treated with RP between 1988 and 2002 at five equal access medical centers. We compared age, as a categorical variable according to decade of life (50 years old or younger, 51 to 60, 61 to 70, and older than 70 years), with the clinical and pathologic variables at RP, as well as the time to biochemical recurrence, using a multivariate Cox proportional hazards model. RESULTS: Age was significantly related to the year of surgery, with the more recently treated patients being younger than less recently treated patients (P <0.001). After controlling for the year of surgery, the younger men had smaller prostates, fewer high-grade tumors on biopsy, and less lymph node metastasis, but a greater percentage of cores with cancer. On multivariate analysis, men 50 years old or younger had significantly lower recurrence rates than did the older men. Moreover, men older than 70 years had significantly greater prostate-specific antigen failure rates than men aged 51 to 70 years or men aged 50 years or younger. CONCLUSIONS: The average age of men undergoing RP has decreased with time. Independent of this, young men have more favorable outcomes after RP than older men. Continued screening to detect prostate cancer among younger men when it is most curable appears warranted.

AB - OBJECTIVES: To examine the relationship between age and biochemical failure after radical prostatectomy (RP), controlling for the year of surgery. Prior studies have suggested that younger men have lower prostate-specific antigen recurrence rates after RP, although none of the prior studies had controlled for the year of surgery. METHODS: We examined the data from 1753 men treated with RP between 1988 and 2002 at five equal access medical centers. We compared age, as a categorical variable according to decade of life (50 years old or younger, 51 to 60, 61 to 70, and older than 70 years), with the clinical and pathologic variables at RP, as well as the time to biochemical recurrence, using a multivariate Cox proportional hazards model. RESULTS: Age was significantly related to the year of surgery, with the more recently treated patients being younger than less recently treated patients (P <0.001). After controlling for the year of surgery, the younger men had smaller prostates, fewer high-grade tumors on biopsy, and less lymph node metastasis, but a greater percentage of cores with cancer. On multivariate analysis, men 50 years old or younger had significantly lower recurrence rates than did the older men. Moreover, men older than 70 years had significantly greater prostate-specific antigen failure rates than men aged 51 to 70 years or men aged 50 years or younger. CONCLUSIONS: The average age of men undergoing RP has decreased with time. Independent of this, young men have more favorable outcomes after RP than older men. Continued screening to detect prostate cancer among younger men when it is most curable appears warranted.

UR - http://www.scopus.com/inward/record.url?scp=2942691916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2942691916&partnerID=8YFLogxK

M3 - Article

VL - 63

SP - 518

EP - 522

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -